Standards Coordinating Body For Gene Cell And Regenerative Medicin
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 561,259 | 139,705 | 421,554 | 36.2 | 0% |
| 2018 | 1,437,196 | 647,586 | 789,610 | 22.4 | 0% |
| 2019 | 682,505 | 904,263 | −221,758 | 13.1 | 0% |
| 2020 | 271,772 | 840,279 | −568,507 | 6.0 | 50% |
| 2021 | 714,927 | 986,620 | −271,693 | 1.8 | 46% |
| 2022 | 794,895 | 896,571 | −101,676 | 0.6 | 61% |
| 2023 | 623,711 | 755,852 | −132,141 | -1.3 | 61% |
In its most recent public year (2023), this organization spent $132,141 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-1.3 months), down from 36.2 in 2017. Staff pay was 61% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works